Cholera as a model In many ways, the well-known story of Dr Snow and the control of cholera in London' is a paradigm for the operation of the biomedical research enterprise in the United States. The relationship between the two extends far beyond the interest in cholera that Dr Kinyoun, the founding father of the National Institutes of Health (NIH), shared with Dr Snow. First, Dr Snow conducted a careful investigation focused upon what -he considered to be the probable mode of disease transmission. Next, he published his results for review and validation by scientific peers. Finally, he actively disseminated the results to insure that the potential health benefits ofhis research were realized.
At the NIH, and particularly at the National Heart, Lung, and Blood Institute (NHLBI>, we consider the development of biomedical advances to be a stepwise process. New knowledge is first acquired through basic, applied, clinical, or population-based research. The new knowledge that shows promise ofcontributing to better diagnosis, therapy, or disease prevention is then validated through clinical trials or other appropriate means. Finally, the validated knowledge is transferred to general medical practice through demonstration programmes and through professional and public education efforts. This is essentially the pattern followed by Dr Snow. Where we differ from Dr Snow, and it is a profound difference, is that his was an individual effort. He developed and validated new knowledge about cholera on his own and only sought the involvement of others in his demonstration project at the Broad Street pump. We do not try to do it all by ourselves. The NHLBI recognizes the need for, and in fact is itself the product of, a cooperative effort among the government, voluntary health organizations, academia, and industry.
Dr Lewis Thomas, the President Emeritus of the Memorial Sloan-Kettering Cancer Center and noted essayist on the philosophy and role of biomedical science, has described the NIH as '. . . standing proof that, at least once in a while, government possesses the capacity to do something unique, imaginative, useful, and altogether right.'2
The concept ofbiomedical research as a cooperative enterprise is surely the aspect of the NIH that Dr Thomas had in mind when he' chose the words 'unique' and 'imaginative'. The involvement of the scientific community is essential not only to the conduct of research, but also to the development of Institute programme initiatives that are relevant to the health needs ofthe country and to the peer review process that insures NIH funds are provided only to the most meritorious research proposals. Because the members of the scientific community are involved from the outset in assuring the relevance and-quality of research to be supported by the Institute, it is relatively easy to secure their commitment to activities designed to apply the results of that research. But we do not limit ourselves to the research community when we seek to ensure the rapid dissemination and application of research advances. Instead, we seek the assistance of all potentially interested parties. We have placed particular emphasis on involving in our prevention and education efforts those industrial concerns that may have an economic interest in the effectiveness of our programmes. An early emphasis on cooperation and epidemiology Both the concept of the NHLBI as leader of a coordinated national research effort and the major Institute emphasis on epidemiological research date from the creation of the National Heart Institute in 1948. The cooperative aspect of the Institute was imprinted upon it at its inception. In the Congressional hearings of 1948 that led up to the establishment of the Institute, supportive testimony was provided by interested members of Congress, representatives of the American Heart Association, and selected members ofthe National Heart Council, an ad hoc group whose membership included many distinguished and well-known public figures. It is noteworthy that the testimony of those who appeared on behalf ofthe National Heart Committee was made particularly convincing by the inclusion of statistics on the incidence of heart disease in the American population and estimates of the attendant costs of treatment and lost productivity.
The result of all those hours of volunteer effort was the National Heart Fortunately, the cooperative spirit that led to the National Heart Act did not terminate with -the establishment of the NHI. Because the National Heart Act also created a National Advisory Heart Council to 'advise, consult with, and make recommendations' regarding the Institute and its 014768/89/ programmes, it was clear from the outset that -© 721989 continued collaboration with the research community, The Royal the voluntary health organization, and public spirited Society of citizens was to be not only encouraged, but actively Medicine sought. The legislative invitation for their participation was apparently well received; the membership of the first National Advisory Heart Council included among its membership many of the individuals who had been active in the campaign to establish the Institute. Notable among them were Dr Paul Dudley White, the pre-emirtent cardiologist ofhis time in the United States, and the well-known philanthropists Mrs Mary Lasker.
With health statistics related to the public health impact of heart disease having provided important supporting evidence in the hearings that led up to its establishment, it is not surprising that biostatistics and epidemiology received early emphasis in the new National Heart Institute. As early as 1949, a Statistical Analysis Branch occupied a central position in the Institute's organization chart.
The role of epidemiology and biostatistics in the NHI was enhanced further when the now famous Epidemiology received a further boost in the Institute when the second Director of the NHI was appointed in 1952. Dr James Watt, a specialist in epidemiology and cholera, served as Director of the NHI from 1952 to 1961. While a specialist in an infectious disease may seem anomalous for the Director of the National Heart Institute, Dr Watt's direction of the Institute during its early formative years and for almost one-quarter of its existence served to guarantee the Institute's extended commitment to epidemiological studies.
A continuing emphasis on cooperation and epidemiology And how have those early Institute characteristics of cooperation with the scientific community and other interested groups and epidemiology as a major research focus of the Institute fared over the years? From even a cursory examination of the present organizational structure ofthe NHLBI, it is clear that epidemiology has retained its stature within the Institute. Today the Institute has a separate division dedicated to epidemiology and clinical applications. the routine contacts between Institute staff and individuals and organizations supported by the Institute as well as chance encounters and discussions that occur at professional meetings and conferences. The 18 member NHLBAC is appointed by the Secretary of Health and Human Services with twothirds of its membership selected from leaders in health and related scientific disciplines and the remainder selected from the general public and from leaders in the fields ofpublic policy, law, health policy, economics and management. By statute, the Council is responsible for reviewing all applications for grantsin-aid received by the Institute and recommending for approval those projects that merit support. In addition, the Council plays a critical role in the process by which the Institute identifies future research initiatives. But before any proposals for new Institute programmes ever reach the stage of review by the NHLBAC, they are first scrutinized and revised by Institute staff and an appropriate advisory committee.
To insure that only the most meritorious proposals for Institute action are ever presented to the NHLBAC, the histitute ha adlapted a formal planning process. The process begins with the advancement of ideas for Institute action by any one of a number of sources. Ideas for epidemiological studies may be proposed by the scientific community through the recommendations of either task forces and workshops organized by the Institute or ofthe Institute advisory committees. They may also be developed directly by Institute staff. Whatever the origin of an idea, the next step is to prepare a formal statement of the proposed initiative for the review and endorsement ofthe Clinical Applications and Prevention Advisory Committee. Proposals endorsed by the committee are then considered by the Division of Epidemiology and Clinical Applications for recommendation to the Director ofthe Institute. Only proposals reviewed axnd approved by the Director are presented to the NHLBAC for their review and endorsement, and only those proposals that receive the approval of the Council are released to the scientific community.
Cooperation for quality It matters not a bit whether a programme released to the community is a grant programme that encourages the design and submission of original research approaches or a contract programme that solicits participation in Institute designed cperative studies; in either case the need for the involvement-and support of the scientific commty does not terminate with its release. Members of the scientific community are relied upon by the Institute to review and evaluate the relative quality of the responses. It is the peer review performed by the scientific community itself that provides the initial quality assessment upon which Institute funding decisions are predicated.
Most of the Institute-initiated epidemiological studies are structured as contracts programmes, with the final selection ofparticipating organizations being made by the Institute staff. Conclusions of the peer review committees provideI the quality aessment against which Institute staff conider such other relevant factors as cost and programme balance. As grant applications, investigator-initiated activities in epidemiology undergo a slightly different review process. While the quality assessment of grant applications is performed by appropriately constituted peer review committees, the Institute determination as to which qualified applications to fund requires the review and approval of the NHLBAC.
So far, we have seen that the scientific community, through its participation in the various advisory bodies and review committees of the NHLBI, is intimately involved not only in the determination of the programmes to be initiated and supported, but also in the selection of the individuals and organizations who are to receive that support. Of course, the scientific community also provides the respondents to the programmes announced by the Institute. But there is another dimension of involvement by the scientific community that is crucial to the continued success of the epidemiological and other scientific programmes of the Institute.
Cooperation for support
The NIH is an agency within the Executive Branch of the United States Government. As such, it is dependent upon the appropriations and budgets determined for it by the Congress ofthe United States. The degree of favour with which Congress views the NIH is due in no small partto the sustained advances in biomedical research and in the health of the American people that have been realized as a result of their previous-confidence in us. Members of Congress are acutely aware of those issue's that directly affect their constituents and the widespread impact of coronary heart disease and other diseases within the Institute's mandate assures that no groups on behalf of the NHLBI reminds the Congress of the degree to which the future health of their constituents and the nation are dependent upon the continued vitality of the Institute.
The support we receive from voluntary health organizations is not limited to appearances before Congress to give testimony in favour of the Institute. Local affiliates of the voluntary organizations meet with their local Congressmen and Senators to urge their continued support for NHLBI activities while representatives of the corresponding national organizations meet with the chairmen and other influential members of relevant Congressional committees.
As in the hearings that led up to the creation of the Institute, basic statistics related to the prevalence and incidence of diseases within the current mandate of the NHLBI constitute some of the most important evidence presented to the Congress. With one American dying from coronary heart disease (CHD) each minute, it is relatively easy to convey the magnitude of the health problem to the United States that CHD still represents. But increasingly, those basic statistics are augmented by evidence related to the-effectiveness of Institute-sponsored opidemio-.logical research in identifying risk factors for the, various diseases within the Institute's mandate and the effectiveness of Institute-sponsored programmes for public and professional education-that are designed to address those risks. members are disinterestec in what we do. The Cooperation and relevance reductions in cardiovascular mortality that have While it is certainly of some interest to the members Dccurred in the United States over the past 20 years of Congress to hear that, through the Framingham have made the Congress particularly receptive to the and other Institute-sponsored epidemiological studies, NHLBI when we appear before it each year as part the significance of hypertension, elevated blood of the annual appropriations hearings. But when we cholesterol, and smoking as risk factors for the appear, we appear to support the budget proposed for development of cardiovascular disease has been firmly us by the Department of Health and Human Services.
established, it is of far greater interest to them to hear Historically, there has been little relation between about the implementation of cooperative programmes what the administration requests for the NIH and designed to insure that the potential health benefits what the Congress ultimately appropriates (Figure 1) associated with reductions in risk factors are realized. and one of the main reasons for that is the involve-Yet, implicit in any discussion with .Congress of ment ofthe scientific communityand the professional such NHLBI programmes as the National High and voluntary health organizations in the appropria-Blood Pressure Education Program, the National tions process.
Cholesterol Education Program, and the NHLBI For example, during the last cycle of appropriation
Smoking Education Program is a recognition of the hearings, testimony in support of the NHLBI was continued importance of epidemiological research to presented by such professional and voluntary health further progress in the control of cardiovascular and organizations as the American College of Cardiology, pulmonary disease. the American Heart Association, the American Lung
The salutary effect of the requirement that we Association, the Cystic Fibrosis Foundation, the report regularly to Congress on our progress and American College of Chest Physicians, the Cooley's plans extends beyond stimulating us to identify Anemia Foundation, the American Society ofHemato-opportunities for effective dissemination programmes. logy, the Juvenile Diabetes Foundations, and the It insures the continued relevance of our programme American Thoracic Society. The appearance of such efforts. The United States is a widely diverse Dolurs (in Miloln) nation; it includes people of many different ethnic ____________________________________ backgrounds. The Congress manifests a particular concern whenever a disease condition is significantly soo _ Ai*roWr" more prevalent among any given subpopulation than o it is among the American population as a whole. For Consequently, we regularly review our programme plans, and especially our portfolio of epidemiological research to determine what additional activities are required. We are careful to include in all of our large scale population-based studies components that are designed to assess the relative prevalence of risk factors and disease among minority group populations and to develop new studies where adequate data for any major population group are lacking. For example, in 1984 the Institute initiated a sizeable new longitudinal study, the Atherosclerosis Risk in Communities (ARIS) study. The objective ofthe study is to compare the prevalence of cardiovascular risk factors and the development ofcardiovascular disease in free-living populations. The study design called for, and the study is now being conducted with, a total of four diverse communities, one of which is predominately black. This year the Institute is adding a new population-based study to address the prevalence and incidence of diseases within the Institute's mandate as well as risk factors for those diseases among American Indians and other native Americans.
But not all of the impetus for relevance in the Institute's epidemiological research-programme comes from the Institute or its advisory committees. Over 50% of the Institute's funding for epidemiological research supports investigator-initiated research (Figure 2 ). Included within that category is the Evans County Study, one of the leading studies of cardiovascular disease among rural blacks. The Evans County Study is an illustrative of another aspect of the cooperative nature of the biomedical research enterprise in the United States. While the Institute, with the aid of its advisory committees and its advisory council, can do much to insure that the programmes it initiates constitute a balanced programme of relevant epidemiological research, balance can only be maintained in the full portfolio of epidemiological research that we support if there is an awareness among the scientific community of what constitutes relevant epidemiological research.
Cooperation and the future So what are the guarantees that the epidemiology supported by the National Heart, Lung, and Blood Institute will maintain its relevance, quality, and applicability? Well, there are no guarantees. Whatever success the NHLBI has achieved to date has been the result of the combined efforts of visionary political leaders, persistent public advocates, and dedicatedscientists. Without the continued cooperation and interest of the political leaders and the public advocates, there may not be adequate funds available to support a comprehensive and effective programme of research, and without the continued involvement of the scientific community, both the quality and the relevance of the research effort would surely suffer. It is the responsibility of the Institute to insure that the politicians and the public advocates continue to see health returns on their investment in time and public funds and that the scientific community continues to trust the Institute to fund only the most meritorious research as judged by their peers.
